INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | ₹0.70 Cr | ₹10 Cr | ₹0.50 Cr | ₹0.50 Cr |
What is the latest Contingent Liabilities ratio of INDEGENE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹0.50 Cr |
| Mar2021 | ₹0.50 Cr |
How is Contingent Liabilities of INDEGENE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹0.70 Cr | -93.07 | |
| Mar2023 | ₹10 Cr | 1,924.05 | |
| Mar2022 | ₹0.50 Cr | 0.00 | |
| Mar2021 | ₹0.50 Cr | - | |
Compare Contingent Liabilities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,820.6 Cr | 0.1% | -5.6% | -21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 0.1% |
-5.6% |
-21% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses